Design and immunogenicity study of a consensus dengue ns1 mRNA vaccine in mice
Dengue virus (DENV) remains a major global health burden, with four antigenically distinct serotypes (DENV-1–4) posing a significant challenge for vaccine development. Dengue non-structural protein 1 (NS1) has been associated with protective immune responses and reduced disease severity, supporting its inclusion in vac...